0001104659-20-029267.txt : 20200304 0001104659-20-029267.hdr.sgml : 20200304 20200304172248 ACCESSION NUMBER: 0001104659-20-029267 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200302 FILED AS OF DATE: 20200304 DATE AS OF CHANGE: 20200304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McLaughlin Gerald W. CENTRAL INDEX KEY: 0001495412 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37508 FILM NUMBER: 20688396 MAIL ADDRESS: STREET 1: 227 WASHINGTON STREET STREET 2: SUITE 200 CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Neos Therapeutics, Inc. CENTRAL INDEX KEY: 0001467652 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270395455 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2940 N. HIGHWAY 360 STREET 2: SUITE 400 CITY: GRAND PRAIRIE STATE: TX ZIP: 75050 BUSINESS PHONE: 972.408.1360 MAIL ADDRESS: STREET 1: 2940 N. HIGHWAY 360 STREET 2: SUITE 400 CITY: GRAND PRAIRIE STATE: TX ZIP: 75050 4 1 a4.xml 4 X0306 4 2020-03-02 0 0001467652 Neos Therapeutics, Inc. NEOS 0001495412 McLaughlin Gerald W. C/O NEOS THERAPEUTICS, INC. 2940 N. HWY 360 GRAND PRAIRIE TX 75050 1 1 0 0 Chief Executive Officer Common Stock 2020-03-02 4 A 0 290000 0 A 314500 D Stock Option (Right to Buy) 1.49 2020-03-02 4 A 0 395000 0 A 2030-03-02 Common Stock 395000 395000 D Represents shares of common stock underlying restricted stock unit grants awarded to the Reporting Person. The restricted stock units will vest in two equal, annual installments beginning on March 2, 2021. This stock option will vest in four equal, annual installments beginning on March 2, 2021. /s/ Gerald McLaughlin 2020-03-04